Signaling molecules derived from the cholesterol biosynthetic pathway: Mechanisms of action and possible roles in human disease

Current Opinion in Lipidology

Volumn 9, Issue 5, 1998, Pages 433-440

  Edwards, Peter A ^a,b,c   Ericsson, Johan ^a  

^a Dept of Biol Chem and Medicine ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; CHOLESTEROL; FARNESOL; GERANIOL; GERANYLGERANIOL; HYDROXYSTEROL; ISOPRENOID; REGULATOR PROTEIN; STEROL DERIVATIVE; UNCLASSIFIED DRUG;

ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; DISEASE ASSOCIATION; GENETIC TRANSCRIPTION; PRIORITY JOURNAL; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION;

ABNORMALITIES, MULTIPLE; CHOLESTEROL; GENE EXPRESSION REGULATION; HUMANS; LIPID METABOLISM, INBORN ERRORS; SIGNAL TRANSDUCTION;

EID: 0031788436     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-199810000-00007     Document Type: Review

References (85)

1. Casey PJ, Seabra MC. Protein prenyltransferases. J Biol Chem 1996; 271:5289-5292.
2. Schafer BL, Bishop RW, Kratunis VJ, Kalinowski SS, Mosley ST, Gibson KM, et al. Molecular cloning of human mevalonate kinase and identification of a missense mutation in the genetic disease mevalonic acidurea. J Biol Chem 1992, 267:13224-13238.
3. Tint GS, Irons M, Elias ER, Batta AK, Frieden R, Chen TS, Salen G. Defective cholesterol biosynthesis association with the Smith-Lemli-Opitz syndrome. N Engl J Med 1994; 330:107-113.
4. Krieger M. The 'best' of cholesterols, the 'worst' of cholesterols: a tale of two receptors. Proc Natl Acad Sci U S A 1998; 95:4077-4080. A succint summary on the function of different receptors that are involved in lipoprotein metabolism.
5. Carstea ED, Morris JA, Coleman KG, Loftus SK, Zhang D, Cummings C, et al. Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis [see comments]. Science 1997; 277:228-231. This study identifies the defective gene associated with Niemann-Pick C1 disease.
6. Loftus SK, Morris JA, Carstea ED, Gu JZ, Cummings C, Brown A, et al. Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene. Science 1997; 277:232-235.
7. Aslanidis C, Ries S, Fehringer P, Buchler C, Klima H, Schmitz G. Genetic and biochemical evidence that CESD and Wolman disease are distinguished by residual lysosomal acid lipase activity. Genomics 1996; 33:85-93.
8. Clayton PT. Disorders of cholesterol biosynthesis. Arch Dis Childhood 1998; 78:185-189.
9. Brown MS, Goldstein JL. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 1997; 89:331-340. An excellent review of SREBP.
10. Ericsson J, Jackson SM, Lee BC, Edwards PA. Sterol regulatory element binding protein binds to a cis element in the promoter of the farnesyl diphosphate synthase gene. Proc Natl Acad Sci U S A 1996; 93:945-950.
11. Guan G, Dai PH, Osborne TF, Kim JB, Shechter I. Multiple sequence elements are involved in the transcriptional regulation of the human squalene synthase gene. J Biol Chem 1997; 272:10295-10302.
12. Wang X, Sato R, Brown MS, Hua X, Goldstein JL. SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis. Cell 1994; 77:53-62.
13. Tontonoz P, Kim JB, Graves RA, Spiegelman BM. ADD1: a novel helix-loop-helix transcription factor associated with adipocyte determination and differentiation. Mol Cell Biol 1993; 13:4753-4759.
14. Duncan EA, Brown MS, Goldstein JL, Sakai J. Cleavage site for sterolregulated protease localized to a leu-ser bond in the lumenal loop of sterol regulatory element-binding protein-2. J Biol Chem 1997; 272:12778-12785.
15. Sakai J, Duncan EA, Rawson RB, Hua X, Brown MS, Goldstein JL. Sterol-regulated release of SREBP-2 from cell membranes requires two sequential cleavages, one within a transmembrane segment. Cell 1996; 85:1037-1046.
16. Hua X, Nohturfft A, Goldstein JL, Brown MS. Sterol resistance in CHO cells traced to point mutation in SREBP cleavage-activating protein. Cell 1996; 87:415-426.
17. Sakai J, Nohturfft A, Cheng D, Ho YK, Brown MS, Goldstein JL. Identification of complexes between the COOH-terminal domains of sterol regulatory element-binding proteins (SREBPs) and SREBP cleavage-activating protein. J Biol Chem 1997; 272:20213-20221.
18. Sakai J, Nohturfft A, Goldstein JL, Brown MS. Cleavage of sterol regulatory element-binding proteins (SREBPs) at site-1 requires interaction with SREBP cleavage-activating protein. J Biol Chem 1998; 273:5785-5793.
19. Rawson RB, Zelenski NG, Nijhawan D, Ye J, Sakai J, Hasan MT, et al. Complementation cloning of S2P, a gene encoding a putative metalloprotease required for intramembrane cleavage of SREBPs. Mol Cell 1997; 1:47-57. This paper reports on the complementation cloning of the Site-2 protease in studies utilizing a mutant cell line.
20. Kim JB, Spotts GD, Halvorsen YD, Shih HM, Ellenberger T, Towle HC, Spiegelman BM. Dual DNA binding specificity of ADD1/SREBP1 controlled by a single amino acid in the basic helix-loop-helix domain. Mol Cell Biol 1995; 15:2582-2588.
21. Athaniker JN, Osborne TF. Specificity in cholesterol; regulation of gene expression by coevolution of sterol regulatory DNA element and its binding protein. Proc Natl Acad Sci U S A 1998; 95:4935-4940.
22. Dooley KA, Millinder S, Osborne TF. Sterol regulation of 3-hydroxy-3-methylglutaryl-coenzyme A synthase gene through a direct interaction between sterol regulatory element binding protein and the trimeric CCAAT-binding factor/nuclear factor Y. J Biol Chem 1998; 273:1349-1356.
23. Jackson SM, Ericsson J, Mantovani R, Edwards PA. Synergistic activation of transcription by nuclear factor Y and sterol regulatory element binding protein. J Lipid Res 1998; 39:767-776.
24. Oliner JD, Andresen JM, Hansen SK, Zhou S, Tjian R. SREBP transcriptional activity is mediated through an interaction with the CREB-binding protein. Genes Dev 1996; 10:2903-2911.
25. Ericsson J, Edwards PA. CBP is required for sterol- and sterol regulatory element binding protein-regulated transcription. J Biol Chem 1998; 273:17865-17870. This study identifies CBP as a coactivator of SREBP-dependent transcription.
26. Shikama N, Lyon J, La Thangue NB. The p300CBP family: integrating signals with transcription factors and chromatin. TIBS 1997; 7:230-236.
27. Currie RA. NF-Y is associated with the histone acetyltransferases GCN5 and P/CAF. J Biol Chem 1998; 273:1430-1434.
28. Martinez-Balbás MA, Bannister AJ, Martin K, Haus-Seuffert P, Meisterernst M, Kouzarides T. The acetyltransferase activity of CBP stimulates transcription. EMBO J 1998; 17:2886-2893.
29. Magana MM, Lin SS, Dooley KA, Osborne TF. Sterol regulation of acetyl coenzyme A carboxylase promoter requires two interdependent binding sites for sterol regulatory element binding proteins. J Lipid Res 1997; 38:1630-1638. The authors demonstrate that SREBP activates the transcription of genes involved in fatty acid synthesis.
30. Magana MM, Osborne TF. Two tandem binding sites for sterol regulatory element binding proteins are required for sterol regulation of fatty-acid synthase promoter. J Biol Chem 1996; 271:32689-32694.
31. Tabor DE, Kim JB, Spiegelman BM, Edwards PA. Transcriptional activation of the stearoyl CoA desaturase 2 gene by sterol regulatory element binding protein/adipocyte determination and differentiation factor 1. J Biol Chem 1998; 273:22052-22058. A gene involved in fatty acid denaturation is shown to be transcriptionally activated by SREBPs/ADD1 via a novel sterol responsive element.
32. Ericsson J, Jackson SM, Kim JB, Spiegelman BM, Edwards PA. Identification of glycerol-3-phosphate acyltransferase as an adipocyte determination and differentiation factor 1- and sterol regulatory element-binding protein-responsive gene. J Biol Chem 1997; 272:7298-7305. SREBP is shown to activate a gene involved in triglycéride synthesis. This further extends the genes and pathways that are regulated by SREBPs.
33. Sato R, Inoue J, Kawabe Y, Kodama T, Takano T, Maeda M. Sterol-dependent transcriptional regulation of sterol regulatory element-binding protein-2. J Biol Chem 1996; 271:26461-26464.
34. Lawler JF, Yin M, Diehl AM, Robers E, Chatterjee S. Tumor necrosis factor-α stimulates the maturation of sterol regulatory element binding protein-1 in human hepatocytes through the action of neutral sphingomyelinase. J Biol Chem 1998; 273:5053-5059.
35. Swinnen JV, Ulrix W, Heyns W, Verhoeven G. Coordinate regulation of lipogenic gene expression by androgens: evidence for a cascade mechanism involving sterol regulatory element binding proteins. Proc Natl Acad Sci U S A 1997; 94:12975-12980.
36. Scneek S, Brown MS, Goldstein JL. Sphingomyelin depletion in cultured cell blocks proteolysis of sterol regulatory element binding proteins at site 1. Proc Natl Acad Sci U S A 1997; 94:11179-11183.
37. Shimomura I, Shimano H, Norton JD, Goldstein JL, Brown MS. Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells. J Clin Invest 1997; 99:838-845.
38. Sheng Z, Otani H, Brown MS, Goldstein JL. Independent regulation of sterol regulatory element-binding proteins 1 and 2 in hamster liver. Proc Natl Acad Sci U S A 1995; 92:935-938.
39. Kim JB, Sarraf P, Wright M, Yao KM, Mueller E, Solanes G, et al. Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1. J Clin Invest 1998, 101:1-9.
40. Shimano H, Norton JD, Hammer RE, Shimomura I, Brown MS, Goldstein JL. Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. J Clin Invest 1996; 98:1575-1584.
41. Shimano H, Horton JD, Shimomura I, Hammer RE, Brown MS, Goldstein JL. Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells. J Clin Invest 1997; 99:846-854.
42. Horton JD, Shimomura I, Brown MS, Hammer RE, Goldstein JL, Shimano H. Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2. J Clin Invest 1998; 101:2331-2339. The authors demonstrate the differential effects of SREBP-1 and SREBP-2 on cholesterol and fatty acid synthesis.
43. Shimano H, Shimomura I, Hammer RE, Herz J, Goldstein JL, Brown MS, Horton JD. Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene. J Clin Invest 1997; 100:2115-2124. This paper reports on the phenotype resulting from deletion of the SREBP-1 gene.
44. Kim JB, Wright HM, Wright M, Spiegelman BM. ADD1/SREBP1 activates PPARγ through the production of endogenous ligand. Proc Natl Acad Sci U S A 1998; 95:4333-4337. This study demonstrates that cells overexpressing ADD1/SREBP-1 produce a ligand that activates the nuclear receptor PPARγ.
45. Kim JB, Spiegelman BM. ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes Dev 1996; 10:1096-1107.
46. Jackson SM, Ericsson J, Edwards PA. Signaling molecules derived from the cholesterol biosynthetic pathway. In: Bittman R, editor. Subcellular biochemistry, vol. 28: cholesterol: its functions and metabolism in biology and medicine. New York: Plenum Press; 1997. pp. 1-21.
47. Correll CC, Ng L, Edwards PA. Identification of farnesol as the non-sterol derivative of mevalonic acid required for the accelerated degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J Biol Chem 1994; 269:17390-17393.
48. Correll CC, Edwards PA. Mevalonic acid-dependent degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in vivo and in vitro. J Biol Chem 1994; 269:633-638.
49. Meigs TE, Roseman DS, Simoni RD. Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase degradation by the nonsterol mevalonate metabolite farnesol in vivo. J Biol Chem 1996; 271:7916-7922.
50. Meigs TE, Simoni RD. Farnesol as a regulator of HMG-CoA reductase degradation: characterization and role of farnesyl pyrophosphatase. Arch Biochem Biophys 1997; 345:1-9.
51. Hampton RY, Bhakta H. Ubiquitin-mediated regulation of 3-hydroxy-3-methylglutaryl-CoA reductase. Proc Natl Acad Sci U S A 1997; 94:12944-12948. Ubiquination of HMGCoA reductase is shown to be important for enzyme degradation.
52. Hampton RY, Gardner RG, Rine J. Role of 26S proteasome and HRD genes in the degradation of 3-hydroxy-3-methylglutaryl-CoA reductase, an integral endoplasmic reticulum membrane protein. Mol Biol Cell 1996; 7:2029-2044.
53. McGee TP, Cheng HH, Kumagai H, Omura S, Simoni RD. Degradation of 3-hydroxy-3-methylglutaryl-CoA reductase in endoplasmic reticulum membranes is accelerated as a result of increased susceptibility to proteolysis. J Biol Chem 1996; 271:25630-25638.
54. Berkhout TA, Simon HM, Patel DD, Bentzen C, Niesor E, Jackson B, Suckling KE. The novel cholesterol-lowering drug SR-12813 inhibits cholesterol synthesis via an increased degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J Biol Chem 1996; 271:14376-14382.
55. Remaley AT, Schumacher UK, Amouzadeh HR, Brewer B Jr, Hoeg JM. Identification of novel differentially expressed hepatic genes in cholesterol-fed rabbits by a non-targeted gene approach. J Lipid Res 1995; 36:308-314.
56. Wang N, Tabas I, Winchester R, Ravalli S, Rabbani LE, Tall A. Interleukin 8 is induced by cholesterol loading of macrophages and expressed by macrophage foam cells in human atheroma. J Biol Chem 1996; 271:8837-8842.
57. Liu Y, Hultén LM, Wiklund O. Macrophages isolated from human atherosclerotic plaques produce IL-8, and oxysterols may have a regulatory functon for IL-8 production. Arterioscler Thromb Vasc Biol 1997; 17:317-323.
58. Kraemer R, Pomerantz KB, Kesav S, Scallen TJ, Hajjar DP. Cholesterol enrichment enhances expression of sterol-carrier protein-2: implications for its function in intracellular cholesterol trafficking. J Lipid Res 1995; 36:2630-2638.
59. Oliveira HCF, Chouinard RA, Agellon LB, Bruce C, Ma L, Walsh A, et al. Human cholesteryl ester transfer protein gene proximal promoter contains dietary cholesterol positive responsive elements and mediates expression in small intestine and periphery while predominant liver and spleen expression is controlled by 5-distal sequences. J Biol Chem 1996; 271:31831-31838.
60. Fielding CJ, Bist A, Fielding PE. Caveolin mRNA levels are up-regulated by free cholesterol and down-regulated by oxysterols in fibroblast monolayers. Proc Natl Acad Sci U S A 1997; 94:3753-3758.
61. Chisolm GM. Cytotoxicity of oxidized lipoproteins. Curr Opin Lipidol 1991; 2:311-316.
62. Hoppe G, Ravandi A, Herrera D, Kuksis A, Hoff HF. Oxidation products of cholesteryl linoleate are resistant to hydrolysis in macrophages, form complexes with proteins, and are present in human atherosclerotic lesions. J Lipid Res 1997; 38:1347-1360.
63. Colles SM, Irwin KC, Chisolm GM. Roles of multiple oxidized LDL lipids in cellular injury: dominance of 7 beta-hydroperoxycholesterol. J Lipid Res 1996; 37:2018-2028.
64. Lizard G, Gueldry S, Decked V, Gambert P, Lagrost L. Evaluation of the cytotoxic effects of some oxysterols and of cholesterol on endothelial cell growth: methodological aspects. Pathologie Biologie 1997; 45:281-290.
65. Harada-Shiba M, Kinoshita M, Kamido H, Shimokado K. Oxidized low density lipoprotein induces apoptosis in cultured human umbilical vein endothelial cells by common and unique mechanisms. J Biol Chem 1998; 273:9681-9687.
66. Babiker A, Andersson O, Lund E, Xiu RJ, Deeb S, Reshef A, et al. Elimination of cholesterol in macrophages and endothelial cells by the sterol 27-hydroxylase mechanism. Comparison with high density lipoprotein-mediated reverse cholesterol transport. J Biol Chem 1997; 272:26253-26261.
67. Björkhem I, Lütjohann D, Breuer O, Sakinis A, Wennmalm A. Importance of a novel oxidative mechanism for elimination of brain cholesterol. Turnover of cholesterol and 24(S)-hydroxycholesterol in rat brain as measured with 1802 techniques in vivo and in vitro. J Biol Chem 1997; 272:30178-30184.
68. Edwards PA, Davis RA. Isoprenoids, sterols and bile acids. In: Vance DE, Vance J, editors. Biochemistry of lipids, lipoproteins and membranes. Holland: Elsevier; 1996. pp. 341-362.
69. Schwartz M, Lund EG, Lathe R, Björkhem I, Russell DW. Identification and characterization of a mouse oxysterol 7α-hydroxylase cDNA. J Biol Chem 1997; 272:23995-24001.
70. Willy PJ, Umesono K, Ong ES, Evans RM, Heyman RA, Mangelsdorf DJ. LXR, a nuclear receptor that defines a distince retinoid response pathway. Genes Dev 1995; 9:1033-1045.
71. Janowski BA, Willy PJ, Devi TR, Falck JR, Mangelsdorf DJ. An oxysterol signaling pathway mediated by the nuclear receptor LXRα. Nature 1996; 383:728-731.
72. Lehmann JM, Kliewer SA, Moore LB, Smith-Oliver TA, Oliver BB, Su JL, et al. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J Biol Chem 1997; 272:3137-3140. This study identifies oxysterols as activators of LXR.
73. Forman BM, Ruan B, Chen J, Schroepfer GJ, Evans RM. The orphan nuclear receptor LXRαis positively and negatively regulated by distinct products of mevalonate metabolism. Proc Natl Acad Sci U S A 1997; 94:10588-10593.
74. Peet DJ, Turley SD, Ma W, Janowski BA, Lobaccaro J-MA, Hammer RE, Mangelsdorf DJ. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXRa. Cell 1998; 93:693-704. This study describes the phenotype resulting from deletion of the LXR gene and this provides important insights into the physiological function of LXR.
75. Lala DS, Syka PM, Lazarchik SB, Mangelsdorf DJ, Parker KL, Heyman RA. Activation of the orphan nuclear receptor steroidogenic factor 1 by oxysterols. Proc Natl Acad Sci U S A 1997; 94:4895-4900.
76. Mellon SH, Bair SR. 25-hydroxycholesterol is not a ligand for the orphan nuclear receptor steroidogenic factor-1 (SF-1). Endocrinology 1998; 139:3026-3029.
77. Miyata KS. McCaw SE, Patel HV, Rachubinski RA, Capone JP. The orphan nuclear hormone receptor LXRa interacts with the peroxisome proliferator-activated receptor and inhibits peroxisome proliferator signaling. J Biol Chem 1996; 271:9189-9192.
78. Porter JA, Young KE, Beachy PA. Cholesterol modification of hedgehog signaling proteins in animal development. Science 1996; 274:255-259.
79. Cooper MK, Porter JA, Young KE, Beachy PA. Teratogen-mediated inhibition of target tissue response to Shh signaling. Science 1998; 280:1603-1607.
80. Strauss E. One-eyed animals implicate cholesterol in development. Science 1998; 280:1528-1529. A short review of the potential role of cholesterol and sonic hedgehog in development.
81. Forman BM, Goode E, Chen J, Oro AE, Bradley DJ, Perlmann T, et al. Identification of a nuclear receptor that is activated by farnesol metabolites. Cell 1995; 81:687-693.
82. Seol W, Choi HS, Moore DD. Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors. Mol Endocrinol 1995; 9:72-85.
83. Zavacki AM, Lehmann JM, Seol W, Willson TM, Kliewer SA, Moore DD. Activation of the orphan receptor RIP14 by retinoids. Proc Natl Acad Sci U S A 1997; 94:7909-7914.
84. Kitareewan S, Burka LT, Tomer KB, Parker CE, Deterding LJ, Stevens RD, et al. Phytol metabolites are circulating dietary factors that activate the nuclear receptor RXR. Mol Biol Cell 1996; 7:1-15.
85. Masuda Y, Nakaya M, Nakajo S, Nakaya K. Geranylgeraniol potently induces caspase-3-like activity during apoptosis in human leukemia U937 cells. Biochem Biophys Res Commun 1997; 234:641-645.